Tech Company Financing Transactions
Conceivable Life Sciences Funding Round
Conceivable Life Sciences, operating out of New York, scored $50 million from Advance Venture Partners, ACME Capital and ARTIS Ventures.
Transaction Overview
Company Name
Announced On
9/15/2025
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series A
Investors
Proceeds Purpose
The funding will support the company's mission to make this Nobel Prize-winning therapy more accessible, scalable, and effective at delivering improved pregnancy results.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
New York, NY Undisclosed
USA
New York, NY Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Conceivable Life Sciences, a NYC-based biotech company which specializes in fertility care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alan Murray
Browse more venture capital transactions:
Prev: 9/14/2025: Via venture capital transaction
Next: 9/15/2025: Divergent Technologies venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs